A significant proportion of the discussion at this week's BioPharmaDispatch conference focused on the need for 'structural' reform while some leaders also called on the industry to get more comfortable with respectful disagreement.
Discussion focused on structural change and 'respectful disagreement'
May 19, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 1 August
August 1, 2025 - - Podcast -
Trump administration takes another step in 'Most Favored Nation' push
August 1, 2025 - - Latest News -
Novartis backs the launch of a new cardiovascular disease program
August 1, 2025 - - Latest News -
Study reveals growing benefit of Lilly therapy for early symptomatic Alzheimer’s disease
August 1, 2025 - - Latest News -
New pharmacy-focused partnership marks the launch of two first-to-market biosimilars
August 1, 2025 - - Latest News -
Arrotex expands haematology-oncology portfolio through Antengene partnership
August 1, 2025 - - Latest News -
AbbVie therapy now available on the PBS for treatment of advanced Parkinson’s
August 1, 2025 - - Latest News